What type of study is this?

This is a Experimental Study study.

October 5, 2025Advanced ScienceOpen Access

Ultrathin Multi‐Doped Molybdenum Oxide Nanodots as a Tunable Selective Biocatalyst

View Full Paper

Ask AI

Bookmark

Authors

BZBaoyue ZhangShenyang Pharmaceutical University FHFarjana HaqueRMIT University SRShwathy RamesanFlorey Institute of Neuroscience and Mental Health

Discussion

Member takes

Implication

Observational analysis reveals cytotoxicity increase by three-fold in HeLa cells using multi-doped molybdenum oxide, indicating a promising alternative for targeted cancer treatments.

Key Points

Cytotoxicity toward HeLa cancer cells increases three-fold in 24 hours compared to healthy controls.
Ultrathin biocompatible molybdenum oxide nanodots generate reactive oxygen species effectively with appropriate dopants.
The method involved testing hydroxyl radicals as agents in ROS-driven degradation in various assays.
These findings support the potential of multi-doped oxides as innovative biocatalysts, minimizing harm to healthy cells.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68e25559d6d66a53c24751db https://doi.org/10.1002/advs.202500643

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis reveals cytotoxicity increase by three-fold in HeLa cells using multi-doped molybdenum oxide, indicating a promising alternative for targeted cancer treatments.

Ultrathin Multi‐Doped Molybdenum Oxide Nanodots as a Tunable Selective Biocatalyst

Discussion

Member takes

Implication

Key Points

Cite This Study

Ultrathin Multi‐Doped Molybdenum Oxide Nanodots as a Tunable Selective Biocatalyst

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider